What is the medication starting with B used to decrease muscle spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Baclofen for Muscle Spasms

Baclofen is the medication starting with "B" used to decrease muscle spasms, recommended as a first-line treatment at doses of 10-30 mg/day with gradual titration. 1, 2

Mechanism and Efficacy

Baclofen is a GABA-B receptor agonist that has documented efficacy for treating muscle spasms, particularly those of spinal origin. 3 It works centrally at the brain stem level to reduce tonic somatic motor activity, influencing both gamma and alpha motor systems. 4

  • Studies demonstrate that 72-80% of patients with spasticity of spinal origin experience effective reduction in muscle spasms with oral baclofen. 5, 6
  • Baclofen reduces both the number and severity of spasms in 76-87% of patients. 6
  • It is particularly effective for severe spasticity resulting from central nervous system injury, demyelinating conditions, and other neuromuscular disorders. 3

Dosing Strategy

Start with 10 mg/day and increase gradually in weekly increments of 10 mg/day up to 30 mg/day to minimize side effects. 2

  • For geriatric patients, start at 5 mg up to three times daily (maximum 15 mg/day initially) with careful monitoring. 2
  • Allow at least 72 hours between dose increases to assess the full effect due to baclofen's long half-life (18 hours, range 8-37 hours). 7, 4
  • Some patients may require doses exceeding 80 mg/day for adequate symptomatic relief, though this exceeds conventional recommendations. 8

Critical Safety Considerations

Never abruptly discontinue baclofen after prolonged use—implement a slow tapering period to prevent potentially life-threatening withdrawal symptoms including seizures, psychic symptoms, and hyperthermia. 3, 1, 2

  • Common side effects include dizziness, somnolence, and gastrointestinal symptoms, which can be minimized by starting low and titrating slowly. 3, 2
  • Monitor for muscle weakness, urinary dysfunction, cognitive effects, and sedation, especially in elderly patients. 2
  • Elderly patients have approximately 1.7-fold higher plasma concentrations, with elderly males showing 2.4-fold increases. 4
  • Baclofen is primarily renally excreted; use with extreme caution in patients with renal impairment as limited data suggest unnecessarily high risk. 5

When to Consider Alternatives

Benzodiazepines may be justified for muscle spasm relief when anxiety and muscle spasm coexist, though they carry a high risk profile in older adults and should generally be avoided. 3

  • Tizanidine is an alternative first-line agent, particularly for spasticity of cerebral origin. 1, 7
  • For refractory cases unresponsive to maximum oral doses, intrathecal baclofen via surgically implanted pump provides >80% improvement in tone and >65% improvement in spasms. 9, 5, 10

Common Pitfalls to Avoid

  • Do not confuse baclofen with other muscle relaxants like cyclobenzaprine, which despite being marketed as "muscle relaxants," have nonspecific effects not actually related to muscle relaxation. 3
  • Cyclobenzaprine is structurally identical to amitriptyline and should not be prescribed with the mistaken belief that it directly relieves muscle spasm. 3, 7
  • Monitor for worsening mental status in patients at risk for hepatic encephalopathy. 2
  • Be aware that many muscle relaxants are associated with greater risk for falls in older persons. 3

References

Guideline

Management of Muscle Spasm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pharmacological Management of Muscle Cramps

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bacloffen (Lioresal) in the long-term management of spasticity.

The Medical journal of Australia, 1976

Guideline

Treatment Options for Severe Muscle Spasms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical and pharmacokinetic aspects of high dose oral baclofen therapy.

The Journal of the American Paraplegia Society, 1992

Research

Intrathecal baclofen pump for spasticity: an evidence-based analysis.

Ontario health technology assessment series, 2005

Research

Continuous intrathecal baclofen for severe spasticity.

Lancet (London, England), 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.